The drug threat to weight loss supplements

- Last updated on GMT

Robinson Pharma marketing vice president, Kenn Israel, discusses the recent GlaxoSmithKline petition for weight loss claims be treated as disease claims, and the potential impact of this on the dietary supplement market.

Robinson Pharma marketing vice president, Kenn Israel, discusses the recent GlaxoSmithKline petition for weight loss claims be treated as disease claims, and the potential impact of this on the dietary supplement market.

Related topics: Regulation & Policy, Suppliers, Supplements

Follow us

Featured Events

View more

Products

View more

Webinars